This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 04 May 2015  |  Asia Pacific  |  Market Research

    Market Trends - Technologies to Reduce Healthcare System Fragmentation in Australia

    A Market Insight by Frost & Sullivan

    Frost & Sullivan presented the 2015 Australia Healthcare Information Technology (IT) Outlook at a live event in Sydney in March. This document compiles key trends and opinions presented at the event with supporting data and figures. 2015 predictions highlight key challenges and unmet healthcare industry needs that can be addressed through meaningfu...

    $850.00
  2. 09 Apr 2015  |  South Asia, Middle East & North Africa  |  Market Research

    Global Haemophilia Therapeutics Market

    Increased use of recombinant and prophylaxis therapies drives growth

    This research service studies the Indian Diabetes market. It provides the number of Type 1 and Type 2 diabetic patients in India across different age groups and forecasts these numbers up to 2030. It provides a detailed analysis of the two major segments of the market, the insulin market segment and the anti-diabetic medications segment, which incl...

    $3,950.00
  3. 08 Apr 2015  |  Asia Pacific  |  Market Research

    Analysis of the TIM (Thailand, Indonesia, and Malaysia) Digital and Computed Radiography Markets

    Technology Enhancements Accelerate Growth of X-ray Imaging

    This research service presents an analysis of the digital and computed radiography markets in Thailand, Malaysia, and Indonesia (TIM). It provides an in-depth analysis of the current trends and market size, as well as regional market drivers and restraints. The study offers revenue forecasts by country and discusses market penetration and market at...

    $3,950.00
  4. 13 Mar 2015  |  Asia Pacific  |  Market Research

    Analysis of the Global Vaccines Delivery Market

    Innovative Technologies and Future Trends for Stakeholders

    The global market for vaccines is estimated to be only 2-3% of the total pharmaceuticals market in 2014; however, this sector has been continuously experiencing a stellar growth rate of 10-15% per year versus the 5-7% seen in the overall market. Currently, the most commonly available vaccines are administered by injection, which makes mass immuniza...

    $4,950.00
  5. 04 Mar 2015  |  Asia Pacific  |  Market Research

    The Most Lucrative Market for CROs in the Asia Pacific in 2015

    This study covers the Russian biopharmaceutical and biomedicine markets. Key segments for the biopharmaceutical market include cytokines, monoclonal antibodies, vaccines, and antibiotics. The biomedicine market includes regenerative medicine, nanomedicine, biocompatible medical materials, diagnostics, post-genomic technologies, and bioinformatics. ...

    $500.00
  6. 03 Mar 2015  |  Asia Pacific  |  Market Research

    Singapore Private Outpatient Diagnostic Imaging Services Market

    Sophisticated Technologies Present Opportunities in a Highly Vibrant Healthcare Industry

    The Singapore private outpatient diagnostic imaging services market offers insights on diagnostic imaging products such as computed tomography scanners, magnetic resonance imaging, X-ray, mammogram, positron emission tomography, and single-photon emission computed tomography used in polyclinics, private hospitals, and diagnostic centers. Procedura...

    $1,500.00
  7. 24 Feb 2015  |  Asia Pacific  |  Market Research

    Analysis of the Global Oncology Drug Delivery Market

    Future Impact of Emerging Technologies

    The global oncology drug delivery market (or oncolytics market) was worth $91.00 billion in 2013 and has been growing at an annual rate of 5.0%. The market, which includes drug delivery systems for cancer therapy and cancer pain, is expected to generate $100.96 billion in 2015. The oral drug delivery systems segment accounted for an estimated 25.0%...

    $4,950.00
  8. 22 Jan 2015  |  Asia Pacific  |  Market Research

    Drivers for Healthcare R&D Investment in Asia-Pacific

    Rise of the APAC R&D Giants

    Investments in Research and Development (R&D) is the key to sustaining innovation and promoting growth in the healthcare industry. Between 2007 and 2012, global investment in R&D in the industry took a detour from US and Europe towards Asia-Pacific (APAC) countries, primarily targeting Australia, Singapore, and South Korea. This research report pre...

    $1,500.00
  9. 14 Jan 2015  |  Asia Pacific  |  Market Research

    Indonesia Healthcare Outlook

    Value Propositions and Market Entry Guides for Investors

    Indonesia has become one of the most attractive markets for investors during 2014-2015. Implementation of the Jaminan Kesehatan Nasional (JKN) scheme, initiated in January 2014, has been one of the major drivers besides the initiatives by the new government elected in 2014. As per the initial reports, patient volumes have significantly increased af...

    $3,950.00
  10. 19 Dec 2014  |  Asia Pacific  |  Market Research

    Patent Cliff and the Future of Generics in Asia

    Trends that will Impact the Market in the Short Term

    The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...

    $2,450.00